Menu
technology

Pharmacists asked which systems use AI. Here are 5 things the software should prove first.

A Reddit thread moved quickly from curiosity to skepticism. That is the right starting point: buyers need a demonstrated workflow, bounded use case, human review, failure path, and measurable result—not an AI badge.

By Editorial desk5 minute read

Pharmacy team evaluating a software workflow
AI is a product claim until a buyer can observe what it changes, who reviews it, and what happens when it is wrong.

1. The social signal: curiosity is colliding with caution

A July 2026 r/pharmacy discussion asked whether newer pharmacy-management systems had adopted AI. Replies ranged from optimism about workflow and documentation to blunt skepticism about installing immature software. The thread is a useful buyer-temperature check, not a market survey or product evaluation.

2–4. Ask for the task, reviewer, and failure path

Name the task the model performs, the information it receives, and the output it produces. Then identify who must review that output and what the user sees when confidence is low, input data are missing, or the suggestion is wrong. A polished happy-path demo does not answer those questions.

NIST's AI Risk Management Framework emphasizes governing, mapping, measuring, and managing risk. For a small practice, that translates into named ownership, a bounded use case, documented testing, monitoring, and a way to stop or work around the feature.

5. Measure the result without counting the label

Choose a result the practice can observe: fewer minutes of duplicate entry, fewer unresolved exceptions, or a more complete work queue. Compare it with the current workflow using synthetic or appropriately protected data. Do not treat adoption, generated text, or vendor-described automation as proof of clinical quality, compliance, or savings.